ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,195Medicare Part D Prescriptions Filled, Including Refills

Rank: 233 out of 2429

$480K Total Retail Price of All Prescriptions

Rank: 305 out of 2429

286 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 286 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 9,289 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
FUROSEMIDE 546 519 1 5
LEVOTHYROXINE SODIUM 415 354 2 3
POTASSIUM CHLORIDE 354 332 3 14
SIMVASTATIN 352 316 4 1
METOPROLOL SUCCINATE 326 311 5 12
LISINOPRIL 269 257 6 2
TRAMADOL HCL 267 251 7 17
AMLODIPINE BESYLATE 191 185 8 4
HYDROCODONE-ACETAMINOPHEN 174 141 S3 9 6
PRAVASTATIN SODIUM 172 155 10 16
GLYBURIDE 170 136 R 11 64
CLOPIDOGREL 160 143 12 31
METOPROLOL TARTRATE 160 136 12 9
OMEPRAZOLE 151 150 14 7
CEPHALEXIN 150 132 15 104
WARFARIN SODIUM 148 147 16 11
ISOSORBIDE MONONITRATE ER 146 135 17 55
ATENOLOL 145 131 18 15
SPIRONOLACTONE 136 110 19 62
CARVEDILOL 124 112 20 21
LOVASTATIN 117 117 21 30
DIOVAN 116 116 22 36
CIPROFLOXACIN HCL 115 108 23 84
ALLOPURINOL 97 76 24 33
NITROGLYCERIN PATCH 92 91 25 155
PLAVIX 90 80 26 44
DONEPEZIL HCL 87 87 27 26
DIGOXIN 87 87 27 43
TAMSULOSIN HCL 86 86 29 29
LOSARTAN POTASSIUM 82 82 30 22
PROPRANOLOL HCL 76 75 31 119
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 76 31 27
LANTUS 75 65 33 45
KLOR-CON M20 72 60 34 60
ALENDRONATE SODIUM 70 66 35 20
CITALOPRAM HBR 68 63 36 19
ZETIA 66 59 37 70
LYRICA 66 66 37 95
LEVOFLOXACIN 65 49 39 87
LEVEMIR 64 57 40 193
METFORMIN HCL 63 63 41 8
NOVOLOG 62 62 42 127
TRIAMTERENE-HCTZ 59 56 43 53
FENOFIBRATE 58 37 44 48
NEXIUM 57 57 45 37
CRESTOR 55 43 46 25
LOSARTAN-HYDROCHLOROTHIAZIDE 54 44 47 73
NITROFURANTOIN 53 53 48 314
PROAIR HFA 53 47 48 41
METOLAZONE 51 51 50 174
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.